Phospholipase Cbeta1b associates with a Shank3 complex at the cardiac sarcolemma
- PMID: 21148417
- DOI: 10.1096/fj.10-171470
Phospholipase Cbeta1b associates with a Shank3 complex at the cardiac sarcolemma
Abstract
Activation of the heterotrimeric G protein Gq causes cardiomyocyte hypertrophy in vivo and in cell models. Our previous studies have shown that responses to activated Gq in cardiomyocytes are mediated exclusively by phospholipase Cβ1b (PLCβ1b), because only this PLCβ subtype localizes at the cardiac sarcolemma. In the current study, we investigated the proteins involved in targeting PLCβ1b to the sarcolemma in neonatal rat cardiomyocytes. PLCβ1b, but not PLCβ1a, coimmunoprecipitated with the high-MW scaffolding protein SH3 and ankyrin repeat protein 3 (Shank3), as well as the known Shank3-interacting protein α-fodrin. The 32-aa splice-variant-specific C-terminal tail of PLCβ1b also associated with Shank3 and α-fodrin, indicating that PLCβ1b binds via the C-terminal sequence. Shank3 colocalized with PLCβ1b at the sarcolemma, and both proteins were enriched in the light membrane fractions. Knockdown of Shank3 using siRNA reduced PLC activation and downstream hypertrophic responses, demonstrating the importance of sarcolemmal localization for PLC signaling. These data indicate that PLCβ1b associates with a Shank3 complex at the cardiac sarcolemma via its splice-variant-specific C-terminal tail. Sarcolemmmal localization is central to PLC activation and subsequent downstream signaling following Gq-coupled receptor activation.
Similar articles
-
The extreme C-terminal region of phospholipase Cbeta1 determines subcellular localization and function; the "b" splice variant mediates alpha1-adrenergic receptor responses in cardiomyocytes.FASEB J. 2008 Aug;22(8):2768-74. doi: 10.1096/fj.07-102558. Epub 2008 Apr 7. FASEB J. 2008. PMID: 18390926
-
Gq-initiated cardiomyocyte hypertrophy is mediated by phospholipase Cbeta1b.FASEB J. 2009 Oct;23(10):3564-70. doi: 10.1096/fj.09-133983. Epub 2009 Jun 29. FASEB J. 2009. PMID: 19564249
-
Phospholipase Cβ1b directly binds the SH3 domain of Shank3 for targeting and activation in cardiomyocytes.Biochem Biophys Res Commun. 2015 Jun 5;461(3):519-24. doi: 10.1016/j.bbrc.2015.04.060. Epub 2015 Apr 21. Biochem Biophys Res Commun. 2015. PMID: 25911318
-
Potential treatment of cardiac hypertrophy and heart failure by inhibiting the sarcolemmal binding of phospholipase Cbeta1b.Curr Drug Targets. 2010 Aug;11(8):1032-40. doi: 10.2174/138945010791591331. Curr Drug Targets. 2010. PMID: 20426766 Review.
-
Subtype-specific roles of phospholipase C-β via differential interactions with PDZ domain proteins.Adv Enzyme Regul. 2011;51(1):138-51. doi: 10.1016/j.advenzreg.2010.10.004. Epub 2010 Oct 28. Adv Enzyme Regul. 2011. PMID: 21035486 Review.
Cited by
-
Structural insights into phospholipase C-β function.Mol Pharmacol. 2013 Oct;84(4):488-500. doi: 10.1124/mol.113.087403. Epub 2013 Jul 23. Mol Pharmacol. 2013. PMID: 23880553 Free PMC article. Review.
-
Golgi localized β1-adrenergic receptors stimulate Golgi PI4P hydrolysis by PLCε to regulate cardiac hypertrophy.Elife. 2019 Aug 21;8:e48167. doi: 10.7554/eLife.48167. Elife. 2019. PMID: 31433293 Free PMC article.
-
Phospholipase Cε hydrolyzes perinuclear phosphatidylinositol 4-phosphate to regulate cardiac hypertrophy.Cell. 2013 Mar 28;153(1):216-27. doi: 10.1016/j.cell.2013.02.047. Cell. 2013. PMID: 23540699 Free PMC article.
-
Genetic variants in PLCB4/PLCB1 as susceptibility loci for coronary artery aneurysm formation in Kawasaki disease in Han Chinese in Taiwan.Sci Rep. 2015 Oct 5;5:14762. doi: 10.1038/srep14762. Sci Rep. 2015. PMID: 26434682 Free PMC article.
-
Compartmentalized cyclic nucleotides have opposing effects on regulation of hypertrophic phospholipase Cε signaling in cardiac myocytes.J Mol Cell Cardiol. 2018 Aug;121:51-59. doi: 10.1016/j.yjmcc.2018.06.002. Epub 2018 Jun 7. J Mol Cell Cardiol. 2018. PMID: 29885334 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources